Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Maurer M, Gimenez-Arnau A, Bernstein JA, Chu CY, et al. Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study. Allergy 2022;77:2175-2184.
PMID: 34773261


Privacy Policy